Caricamento...
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
AIMS: SARS–CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein discussing a possible novel therapeutic tool for COVID-19. METHODS: Virus binds to the cell surface receptor ACE2; indeed, recen...
Salvato in:
| Pubblicato in: | Acta Diabetol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Milan
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275134/ https://ncbi.nlm.nih.gov/pubmed/32506195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-020-01539-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|